INDICATION XPHOZAH (tenapanor), 30 mg BID, is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response ...
It was a good turnout for Black River Memorial Hospital’s kidney dialysis presentation and tour of the new service wing Thursday, Jan. 11. Jennifer Lisowski, R.N., is leaving her post as head of ...
– The ATEV™ was observed to have superior duration of use over 24 months compared to autogenous fistula in high-need subgroups with historically poor outcomes with AV fistula procedures – – The ...
Please provide your email address to receive an email when new articles are posted on . The use of technicians to assist in delivering dialysis to the end-stage kidney disease population has been a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results